Cargando…

Small Activating RNA Modulation of the G Protein‐Coupled Receptor for Cancer Treatment

G protein‐coupled receptors (GPCRs) are the most common and important drug targets. However, >70% of GPCRs are undruggable or difficult to target using conventional chemical agonists/antagonists. Small nucleic acid molecules, which can sequence‐specifically modulate any gene, offer a unique oppor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Yunfang, Ke, Ran, Zhang, Qingyu, Lan, Wenjun, Yuan, Wanjun, Chan, Karol Nga Ieng, Roussel, Tom, Jiang, Yifan, Wu, Jing, Liu, Shuai, Wong, Alice Sze Tsai, Shim, Joong Sup, Zhang, Xuanjun, Xie, Ruiyu, Dusetti, Nelson, Iovanna, Juan, Habib, Nagy, Peng, Ling, Lee, Leo Tsz On
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475523/ https://www.ncbi.nlm.nih.gov/pubmed/35712764 http://dx.doi.org/10.1002/advs.202200562

Ejemplares similares

Small Activating RNA Modulation of the G Protein‐Coupled Receptor for Cancer Treatment (Adv. Sci. 26/2022)
por: Xiong, Yunfang, et al.
Publicado: (2022)

Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
por: Juiz, Natalia Anahi, et al.
Publicado: (2019)

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
por: Lomberk, Gwen, et al.
Publicado: (2019)

Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022)

Redox-sensitive TP53INP1 SUMOylation as an oxidative stress sensor to activate TP53
por: Bonacci, Thomas, et al.
Publicado: (2014)

Dendrimer nanosystems for adaptive tumor-assisted drug delivery via extracellular vesicle hijacking
por: Jiang, Yifan, et al.
Publicado: (2023)

Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition
por: Gajate, Consuelo, et al.
Publicado: (2021)

E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments
por: Lan, Wenjun, et al.
Publicado: (2018)

The Role of Endocrine G Protein-Coupled Receptors in Ovarian Cancer Progression
por: Zhang, Qingyu, et al.
Publicado: (2017)

Application of Nanoparticles for Targeting G Protein-Coupled Receptors
por: Ma, Xin, et al.
Publicado: (2018)

FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer
por: Zhang, Qingyu, et al.
Publicado: (2019)

Elucidating combinatorial histone modifications and crosstalks by coupling histone-modifying enzyme with biotin ligase activity
por: Lau, Priscilla Nga Ieng, et al.
Publicado: (2013)

Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
por: Fraunhoffer, Nicolas Alejandro, et al.
Publicado: (2022)

Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence
por: Molejon, Maria Inés, et al.
Publicado: (2015)

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma
por: Bian, Benjamin, et al.
Publicado: (2019)

Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)
por: Bian, Benjamin, et al.
Publicado: (2019)

Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells
por: Wu, Changjie, et al.
Publicado: (2018)

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022)

Mechanism of PAP I gene induction during hepatocarcinogenesis: clinical implications.
por: Dusetti, N. J., et al.
Publicado: (1996)

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance
por: Kaoutari, Abdessamad El, et al.
Publicado: (2021)

Geometric and dosimetric consequences of intra-fractional movement in single isocenter non-coplanar stereotactic radiosurgery
por: Fung, Nelson Tsz Cheong, et al.
Publicado: (2023)

Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress
por: Zhang, Qingyu, et al.
Publicado: (2019)

A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis
por: Mohamed Abd-El-Halim, Yousra, et al.
Publicado: (2021)

Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
por: Du, Bowen, et al.
Publicado: (2016)

ACSL1-induced ferroptosis and platinum resistance in ovarian cancer by increasing FSP1 N-myristylation and stability
por: Zhang, Qingyu, et al.
Publicado: (2023)

Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
por: Shim, Joong Sup, et al.
Publicado: (2014)

Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT
por: Liu, Yifan, et al.
Publicado: (2020)

Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma
por: Siret, Carole, et al.
Publicado: (2018)

Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers
por: El Kaoutari, Abdessamad, et al.
Publicado: (2023)

Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer
por: Liu, Juan, et al.
Publicado: (2021)

Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2023)

Cholesterol Trafficking: An Emerging Therapeutic Target for Angiogenesis and Cancer
por: Lyu, Junfang, et al.
Publicado: (2019)

The pancreatitis-associated protein VMP1, a key regulator of inducible autophagy, promotes Kras(G12D)-mediated pancreatic cancer initiation
por: Loncle, C, et al.
Publicado: (2016)

Synthetic lethality of RB1 and aurora A is driven by stathmin-mediated disruption of microtubule dynamics
por: Lyu, Junfang, et al.
Publicado: (2020)

Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma
por: Molejon, Maria Inés, et al.
Publicado: (2015)

Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells
por: Zhang, Baoyuan, et al.
Publicado: (2020)

Antidepressant drug sertraline modulates AMPK-MTOR signaling-mediated autophagy via targeting mitochondrial VDAC1 protein
por: Hwang, Hui-Yun, et al.
Publicado: (2020)

GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
por: Martinelli, Paola, et al.
Publicado: (2017)

OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients
por: Vachenc, Sébastien, et al.
Publicado: (2022)

TRIM family proteins: roles in proteostasis and neurodegenerative diseases
por: Zhu, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gqc7sdm9pqueld286dohrb7he3